Platelets as pathogenetic effectors and killer cells in cerebral malaria

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (USA) under Award Number U19AI089676, as well as by the National Health and Medical Research Council and the Australian Research Council (Australia). G Grau received a research grant from Novartis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SC Wassmer discloses National Institute of Allergy and Infectious Diseases of the National Institutes of Health (USA) award number U19AI089676. GER G discloses National Health and Medical Research Council and the Australian Research Council (Australia), research grant from Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.